Enlicitide is an impressive scientific achievement.
But is the first oral PCSK9 inhibitor really a game-changer — or another example of how prevention rewards novelty over implementation?
My latest for @statnews.com
www.statnews.com/2026/07/22/l...
statnews.com
I’m a cardiologist. I’m not sure the new cholesterol drug enlicitide is a game-changer
“In truth, I don’t anticipate prescribing patterns changing immediately,” cardiologist Vishal Khetpal writes of the new cholesterol drug Lipfendra.